Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

McGill University

$100,000.00

Horticultural and production research of medical plants for EXKA Inc.

FY 2022-23

Summary
The legal status of cannabis is shifting, causing a rapidly expanding market in North America and Europe. Due to its previous listing as an illicit drug and current status as a controlled substance, knowledge gaps exist in cannabis production and processing. While the number of clinical applications for cannabis is growing, validated methods and internationally recognized guidelines for cannabis production are extremely limited. This lack of standards has resulted in conflicting methods that have led to varied product yield, potency and quality. In Canada, the full legalization of cannabis allows industry and researchers to work together toward standardizing cannabis production, postharvest handling and processing. McGill University is working with EXKA Inc to develop a research program to address some of these challenges that will contribute to the development of optimized methods that will improve medicinal plants (basil, hops and cannabis) during growth through nutrient and fertilizer management, post-harvest processing (drying, grinding, and storage) and extraction of medicinally important cannabis compounds. Poorly understood factors that impact the accumulation of these compounds in plants will be explored. For instance, identifying growth conditions that could influence cannabis compound biosynthesis will allow for improved production that maximizes compound accumulation. Importantly, major objectives include the evaluation of common plant processing, extraction and purification techniques for medicinal-grade cannabis products. Standardized tests will be used to determine if compound yield and/or product quality are affected at any step in the production process.
Program
Collaborative Research and Development Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
543704-2019
Name nom
Lefsrud, Mark MG
Department département
Bioresource Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2019
Award amount
100000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
1200
Research subject group en
Agricultural engineering
Research subject group fr
Génie rural
Research subject en
Agricultural engineering
Research subject fr
Génie rural
Installment
inst:5
Partie
1
Nb partie
5
Application title
Horticultural and production research of medical plants for EXKA Inc.
Application summary
The legal status of cannabis is shifting, causing a rapidly expanding market in North America and Europe. Due to its previous listing as an illicit drug and current status as a controlled substance, knowledge gaps exist in cannabis production and processing. While the number of clinical applications for cannabis is growing, validated methods and internationally recognized guidelines for cannabis production are extremely limited. This lack of standards has resulted in conflicting methods that have led to varied product yield, potency and quality. In Canada, the full legalization of cannabis allows industry and researchers to work together toward standardizing cannabis production, postharvest handling and processing. McGill University is working with EXKA Inc to develop a research program to address some of these challenges that will contribute to the development of optimized methods that will improve medicinal plants (basil, hops and cannabis) during growth through nutrient and fertilizer management, post-harvest processing (drying, grinding, and storage) and extraction of medicinally important cannabis compounds. Poorly understood factors that impact the accumulation of these compounds in plants will be explored. For instance, identifying growth conditions that could influence cannabis compound biosynthesis will allow for improved production that maximizes compound accumulation. Importantly, major objectives include the evaluation of common plant processing, extraction and purification techniques for medicinal-grade cannabis products. Standardized tests will be used to determine if compound yield and/or product quality are affected at any step in the production process.